Full text is available at the source.
Abstract
EGCG (25, 50, or 75 mg/kg) significantly inhibited sevoflurane-induced neuroapoptosis in neonatal mice.
- Sevoflurane exposure in neonatal mice led to neuroapoptosis, indicated by Fluoro-Jade B staining and TUNEL.
- EGCG administration resulted in increased expression of anti-apoptotic proteins such as Bcl-2 and survivin.
- Activation of the PI3K/Akt pathway was observed following EGCG treatment, with elevated levels of Akt and mTORc1.
- EGCG countered the downregulation of cAMP/CREB and BDNF/TrkB signalling caused by sevoflurane.
- Increased mRNA levels of BDNF and TrkB were detected after EGCG treatment.
- Mice treated with EGCG showed improved performance in learning and memory tests, as measured by the Morris water maze.
Simplified